Protagonist Therapeutics
PTGX
PTGX
66 hedge funds and large institutions have $208M invested in Protagonist Therapeutics in 2019 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 30 increasing their positions, 16 reducing their positions, and 13 closing their positions.
Holders
66
Holders Change
+2
Holders Change %
+3.13%
% of All Funds
1.44%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
15
Increased
30
Reduced
16
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
BlackRock
New York
|
$12.3M |
2 |
BBA
2
Baker Bros. Advisors
New York
|
$12.1M |
3 |
ACP
3
Acuta Capital Partners
Redwood City,
California
|
$8.13M |
4 |
![]()
4
JPMorgan Chase & Co
New York
|
$6.69M |
5 |
VMI
5
VHCP Management III
New York
|
$13M |